News update from Physiomics February 2024
Leading mathematical modelling company, supporting oncology drug development. From us to you - curated cutting-edge research and insights. Welcome to our newsletter, where we share the latest updates from Physiomics and offer insights on the pivotal news shaping the dynamic world of drug development. Top news Welcoming Peter Sargent as newly appointed CEO Peter, who joined Physiomics in September 2023 as Chief Operating Officer, has now been appointed to...
Read More